Anne Borgman, M.D. is a seasoned pharmaceutical executive with over 20 years of expertise in hematology oncology drug development. Currently, they serve as Principal at AEB Hematology Oncology Development Consulting and hold multiple board positions, including at Curis and NiKang Therapeutics Inc. Previously, they have held key leadership roles at organizations such as Exelixis, Jazz Pharmaceuticals, and Abbott Laboratories, where they led global oncology initiatives. They completed the Stanford Executive Program at Stanford University Graduate School of Business in 2022 and have contributed as a consulting associate professor at Stanford's School of Medicine.
This person is not in the org chart
This person is not in any teams
This person is not in any offices